Literature DB >> 14661676

Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

James Stephen Krinsley1.   

Abstract

OBJECTIVE: To investigate the relationship between hyperglycemia and hospital mortality in a heterogeneous group of critically ill patients. PATIENTS AND METHODS: Retrospective data were reviewed for 1826 consecutive patients whose glucose values were obtained during their intensive care unit stay at The Stamford Hospital in Stamford, Conn, between October 1, 1999, and April 4, 2002.
RESULTS: Mean and maximum glucose values were significantly higher among nonsurvivors than among survivors for the entire group (P < .001) and for each subgroup except for patients with septic shock. The lowest hospital mortality, 9.6%, occurred among patients with mean glucose values between 80 and 99 mg/dL. Hospital mortality increased progressively as glucose values increased, reaching 42.5% among patients with mean glucose values exceeding 300 mg/dL. Within each of 3 groupings of Acute Physiology and Chronic Health Evaluation II (APACHE II) scores (0-14; 15-24; > or = 25), mean and maximum glucose values were higher among nonsurvivors than among survivors.
CONCLUSION: Even a modest degree of hyperglycemia occurring after intensive care unit admission was associated with a substantial increase in hospital mortality in patients with a wide range of medical and surgical diagnoses. Analysis of glucose values added predictive power above that achieved by APACHE II scores alone. These results have important implications for the glycemic management of critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661676     DOI: 10.4065/78.12.1471

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  279 in total

1.  Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit.

Authors:  Kupper A Wintergerst; Michael B Foster; Janice E Sullivan; Charles R Woods
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  Critical illness hyperglycemia in pediatric cardiac surgery.

Authors:  Kalia P Ulate; Shekhar Raj; Alexandre T Rotta
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

3.  Stochastic targeted (STAR) glycemic control: design, safety, and performance.

Authors:  Alicia Evans; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Sophie Penning; Fatanah Suhaimi; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

4.  Interface design and human factors considerations for model-based tight glycemic control in critical care.

Authors:  Logan Ward; James Steel; Aaron Le Compte; Alicia Evans; Chia-Siong Tan; Sophie Penning; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

5.  Intensive glucose control in the ICU: an expert interview with James S. Krinsley, MD by Antonios Liolios.

Authors:  James S Krinsley
Journal:  MedGenMed       Date:  2004-04-12

6.  Can dexamethasone be useful in community-acquired pneumonia?

Authors:  Paola Fracasso; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2011-11-25       Impact factor: 3.397

7.  Assessing inpatient glycemic control: what are the next steps?

Authors:  Curtiss B Cook; Kay E Wellik; Gail L Kongable; Jianfen Shu
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

8.  Are tight glycemic targets achieved through intensive insulin infusion still applicable in the intensive care unit?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-01

9.  Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients.

Authors:  S Rijkenberg; S C van Steen; J H DeVries; P H J van der Voort
Journal:  J Clin Monit Comput       Date:  2017-12-07       Impact factor: 2.502

10.  Inpatient Management of Diabetes Mellitus among Noncritically Ill Patients at University Hospital of Puerto Rico.

Authors:  Myriam Zaydee Allende-Vigo; Rafael A González-Rosario; Loida González; Viviana Sánchez; Mónica A Vega; Milliette Alvarado; Raul O Ramón
Journal:  Endocr Pract       Date:  2014-05       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.